- Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial2015 | First Faculty of Medicine
- Neurophysiological evidence for muscle tone reduction by intrathecal baclofen at the brainstem level2011 | Third Faculty of Medicine
- Early use of Xeomin neurotoxin for local anti-spasticity therapy for pes equines after acquired brain injury (ABI)2011 | First Faculty of Medicine
- Selective posterior rhizotomy in the treatment of cerebral palsy, first experience in Czech Republic2003 | Second Faculty of Medicine
- Treatment of spasticity in chronic spinal cord injury2009 | Third Faculty of Medicine
- Early manifestation of spasticity after first stroke in the territory of the internal carotid artery. A prospective multicenter study2018 | First Faculty of Medicine
- Selective posterior rhizotomy in the treatment of severe spasticity in cerebral palsy2004 | Second Faculty of Medicine
- Treatment of spasticity2023 | Third Faculty of Medicine
- Prevalence and evolution of spasticity in patients suffering from first-ever stroke with carotid origin: a prospective, longitudinal study2019 | First Faculty of Medicine
- Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties2012 | Third Faculty of Medicine
- Modulation of Motor Cortex Activity After Intrathecal Baclofen Delivery in Chronic Thoracic Spinal Cord Injury2022 | Third Faculty of Medicine
- Possibilities of using distance therapy and telerehabilitation in occupational therapy in patients after acquired brain injury - pilot study2021 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- Efficacy and safety of abobotulinumtoxinA in spastic lower limb : Randomized trial and extension2017 | First Faculty of Medicine
- When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?2021 | First Faculty of Medicine